Observational studyScientific reports2026
Sonographic evaluation of fetal abdominal subcutaneous tissue in pregnancies complicated by gestational and type 1 diabetes mellitus.
Observational study in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To perform a comparative analysis of fetal abdominal fat mass (AFM) thickness in women diagnosed with gestational (GDM) and type 1 diabetes mellitus (T1DM), and to evaluate the efficacy of the ultrasonographic AFM measurement in the estimation of the fetal birth-weight (FBW) and prediction of fetal macrosomia. A total of 245 participants were recruited for this prospective observational cohort study, including women with diet-controlled GDM (GDMG1) (n = 50), insulin-controlled GDM (GDMG2) (n = 50), T1DM (n = 50) as well as non-diabetic control patients (n = 95). In each participant measurements of the AFM in conjunction with the standard fetal biometric parameters were performed within the 72 h period prior to delivery. Fetal macrosomia was defined as birth-weight ≥ 4000 g irrespective of gestational age. After adjustment for confounding factors, median AFM and abdominal circumference (AC) measurements as well as the FBW were significantly higher among patients with T1DM as compared to other groups (p < 0.05). In each group both AFM and AC measurements showed strong positive correlations with the FBW (p < 0.001). Two new models comprising maternal (body mass index) and/or ultrasound-derived parameters (biparietal diameter, AC, AFM) for the FBW estimation were constructed. Both equations provided significantly lower mean absolute percent error among GDMG1 and T1DM women as compared to the Hadlock formula (p < 0.05). In addition novel equation for the prediction of fetal macrosomia, utilizing both AC and AFM measurements, yielded sensitivity of 84.8%, specificity 91.9%, positive predictive value 62.2% and negative predictive value of 97.5% within the total study population. In women with GDM/T1DM, the incorporation of the AFM measurement into equations for the FBW estimation provided better accuracy compared to standard formulas and increased the detection of fetal macrosomia. Further validation in large-scale multicenter studies is necessary prior to clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.